You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 270 No. 11, September 15, 1993 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communication
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Racial Equity in Renal Transplantation

The Disparate Impact of HLA-Based Allocation

Robert S. Gaston, MD; Ian Ayres, JD, PhD; Laura G. Dooley, JD; Arnold G. Diethelm, MD

JAMA. 1993;270(11):1352-1356.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

KIDNEY transplantation from either a living related or cadaveric donor is optimal treatment for most patients with end-stage renal disease (ESRD).1 However, due to a critical shortage of organ donors, while more than 23 000 Americans await a suitable cadaveric kidney, fewer than 8000 receive transplants each year.2,3 Approximately one third of ESRD patients in this country are African American (black), a proportion threefold greater than the representation of this racial group in the general population (12%).1 Recently, the Inspector General reported that blacks are less likely than whites to receive a transplant, with almost double the waiting time.4 Currently, cadaveric kidneys are allocated according to a federally mandated system based on quality of HLA matching. This policy is based on evidence that antigenic similarity between donor and recipient may enhance cadaveric graft survival and should be the primary factor influencing distribution.5 Gjertson and colleagues . . . [Full Text PDF of this Article]


Author Affiliations

From the Departments of Medicine (Dr Gaston) and Surgery (Drs Gaston and Diethelm), University of Alabama at Birmingham; Stanford Law School (Dr Ayres), Palo Alto, Calif; and Valparaiso (Ind) University School of Law (Ms Dooley).


Footnotes

Reprint requests to 625 Tinsley Harrison Tower, University of Alabama at Birmingham, UAB Station, Birmingham, AL 35394 (Dr Gaston).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.